| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |